Author's Instructions
Instructions for Authors
Manuscripts for JRNM are accepted on condition that the work is original and has not been previously published except in abstract form, and is not concurrently under review for publication elsewhere. All the manuscripts are peer reviewed. Copyright of the manuscripts accepted for publication, including the right to reproducethe article in all forms and media, shall be assigned exclusively to the SRNM.
Manuscript Categories
The JRNM welcomes manuscripts in the following categories: Original Research Articles, Reviews, Clinical/Research Briefs, Practical Aspects Articles, Case Studies, Patient Education Material, Letters to the Editor, and Supplements. Authors should adhere to the guidelines provided for each type of manuscript. All the manuscripts will be accompanied with an abstract.
All individuals listed as authors must fulfill the following criteria for authorship. Each author must have participated sufficiently in the work to take public responsibility for the content of the paper and must approve of the final version of the manuscript. Authorship should be based on substantive contributions to each of the following: (1) conception and design of the study; (2) generation, collection, assembly, analysis and/or interpretation of data; (3) drafting and/or revision of the manuscript; and (4) approval of the final version of the manuscript. The author who is named as the corresponding author on the manuscript's title page must be the individual to whom all Editorial-related correspondence is directed.
The abstract page should include the title of the manuscript, but no other identifying information. A structured abstract format should be used for "Original Research" and "Cinical/Research Brief " using the following headings: (1) Introduction, (2). Objective: clear statement of purpose of study; (3).material and methods; (4) Setting: context in which the study was conducted; (5) Subjects: demographics, selection criteria, control group used; (6) Intervention: methodology, description of treatment used; (7) Main outcome measure: variable used to assess intervention effect; (8) Results: primary findings of the study; and (9) Conclusion: brief summary of the results directly supported by evidence. The abstract limit is 300 words or fewer. A list of approximately five keywords (to be used for indexing) should appear at the end of the abstract.
Title Page
The title page should include: (1) the title of the manuscript; (2) the name and degree(s) of each author(s); (3) the current title(s) and affiliation(s) of the author(s); (4) the corresponding author's name, address, telephone and fax numbers, and email address; (5) ethical approval (6) word counts for the abstract and the body of the manuscript (excluding, references, tables and figures); (7) a short title (45 characters or fewer, including spaces) to be used as a running head; and (8) acknowledgements if authors wish to express thanks or acknowledge assistance. All individuals who contributed to the writing of the manuscript but who do not qualify as authors must be named in this section. Authors are responsible for informing all listed individuals/ parties that they are being mentioned in the manuscript and for obtaining their approval prior to publication.

Original Research: Original research articles are full length reports that cover topics relevant to renal nutrition dietetics or renal nutrition science (hypertension, diabetes, obesity, hepato-billiary diseases, dialysis therapies and kidney transplantation) for both adult and pediatric issues. To be published, the work must be original. Observations contributions will also be acceptable. In addition, other considerations for evaluating the acceptability of a submitted manuscript include its relevance, merit, soundness of the experimental design, validity of methodology, appropriateness of conclusions, and quality of presentation.

Original Research manuscripts should be organized as follows: title page, name of the authors, affiliation, support and financial disclosure, abstract (introduction, objectives, material methods, results and conclusion not exceeding 300 words ), introduction, methods, results, discussion, practical application, acknowledgments, references, tables, and legends and figures. All pages should be numbered consecutively, starting with the title page as page one. Original Research manuscripts, in general, should not exceed 4,000 words (minimum 2,500), excluding references. Number of tables and illustrations should not exceed 6 and should be limited to those most pertinent to the study without duplicating findings in the text. The editor reserves the right to publish excessively long tables as online-only material. Failure to comply with length restrictions may result in a delay in processing the paper.
State the purpose of the research, rationale and background of the study or observation; cite only pertinent references. The "Introduction" should be limited to 400 words.
Repeatabilty of study important. Provide sufficient detail so that the study can be repeated. Describe new methods in detail; report accepted methods briefly with references. Ethical approval should be mentioned.
Use of Trade Names

Trade names should be avoided. If naming a product trade name cannot be avoided, the trade names of other like products should also be mentioned, and first use should be accompanied by the superscript symbol ™ or ®, followed in parentheses by the owner's name. If a product trade name is used, the product should be described in sufficient detail so that professionally trained readers can understand the nature of the product.

The mention of critical, especially novel, supplies and pieces of equipment ought to be followed, in parenthesis, by name of manufacturer or provider, and on the first mention only, city, state/province, and country.

Describe statistical methods with enough detail to enable reader, with access to the original data, to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (e.g., class intervals CIs, standard deviation SDs, or standard error of mean SEs), even for differences that were not significant. Report sample size, number of observations. Specify computer programs used, including the version number and the manufacturer's name and location. Include general descriptions of statistical methods in the "Methods" section and specific descriptions in each table and figure legend. Indicate whether variables were transformed for analysis. Describe hypotheses and the statistical tests that were used, and what the outcome and explanatory variables were (where appropriate). Indicate the level of significance used in tests if different from the conventional 2-sided 5% alpha error and whether or what type of adjustment was made for multiple comparisons. Specify statistical methods used to analyze results.
Present the results in a logical sequence in the text, tables, and figures. Emphasize and summarize only important observations. Do not present data from individual subjects except in case studies.
This section should not exceed 1000 words (1200 in exceptional cases). Emphasize concisely the novel and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material presented in the "Introduction" or "Results." Compare results with previously reported. Link conclusions with the goals of the study. Indicate what new information is contributed by the present study.
Practical Application
This is a message of reality and practical importance to practicing clinician and the potential clinical application of the research presented in the paper. Keep the description short no more than 2 to 3 sentences. Refrain from making unreasonable claims that cannot be derived from the work described in the paper.
These are comprehensive, quantitative reviews of specific renal nutrition topics (renal science: hypertension, diabetes, obesity, hepato-billiary diseases, dialysis therapies and kidney transplantation) of clinical relevance, Traditional or meta-analysis are welcome. Letters of interest are also welcomed. Reviews should address topics with an extensive body of literature to provide a critical summary of the current evidence and applications. In some cases, review articles may also address an emerging topic with limited literature to better demonstrate the need for more research, but if the focus of the article is on a clinical practice issue, this might better be presented as a "Practical Aspects" article.
Clinical/Research Briefs

Clinical/research briefs are submitted in an abbreviated manuscript format that presents clinical practice experience, preliminary research findings (basic or clinical), or professional observations in a shortened report form. Length usually should not exceed six double-spaced pages, not including references, tables and figures.
Clinical/Research Briefs should be organized as follows: title page, support and financial disclosure, abstract, introduction, methods, results, discussion, practical application, acknowledgments, references, tables, and legends and figures. All pages should be numbered consecutively, starting with the title page as page one.

Practical Aspects
The Journal welcomes manuscripts about a specific renal nutrition topic of clinical relevance for the provider of nutrition or medical care to patients with kidney disease. Contributions to this section are detailed protocols, forms, or other such materials that are successfully utilized for delivery of nutrition care or medical, nursing or psychological care that has a nutrition component.
Material submitted to the Practical Aspects section should include: (1) a title page; (2) abstract (abstract (introduction, objectives, material methods, results and conclusion not exceeding 200 words ); (3) an introduction and purpose; (4) a body, subject in logical order using appropriate headings and subheadings; (5) references and, (6) tables and figures, when appropriate.
Case Studies
This detailed scenario should illustrate a patient care situation that benefited from nutrition intervention. Typically, it should consist of a brief clinical and nutrition history, and a detailed nutrition intervention plan with discussion of recommendations focused on practical application. Appropriate laboratory values, anthropometric measurements, and clinical parameters should be provided.
Patient Education
This section includes educational handout for patient distribution. Patient education materials are published online only, although they are referenced in the Table of Contents of the print edition. Submissions for Patient Education should include introduction explaining the rationale for the development of the material and, when appropriate, how it should be used. Text should be clear and concise and illustrations should be contained on two pages with expanded type.
Letters to the Editor
Letters should be restricted to scientific commentary about materials published in JRNM or to topics of general interest to professionals working in the field of renal nutrition science and dietetics. Letters must be double-spaced, should include a title page, should have no more than 10 references, and should not exceed 700 words. All letters will be subjected to editorial review and decision before acceptance. The JRN does not accept letters that are unrelated to a specific, recently published article; that contain extensive unpublished data; or that engage in personal slander or invective.
The JRNM publishes funded supplements after approval and review by the Editorial Office. Initial inquiries and proposals for supplements should be directed to Dr Anil Bhalla Editor-in-Chief, Journal of Renal Nutrition at
Proceedings Papers
Manuscript submissions from Proceedings must include a 200 word abstract, a main body of about 2,000 words, one figure or table and no more than 20 references. In rare circumstances, up to 2 figures may be considered following discussion with the editors.

*NOTE : Patient Education and Product Updates are accepted for publication solely on the JRNM website. They will be listed in the printed table of contents. There are no charges for color figures; however, they will be subject to the same copyright laws as the printed edition.
Proceedings Papers
  JRNM follows internationally accepted guidelines for Ethics in publishing. and Ethical guidelines for journal publication.  
Copyright Transfer
The Copyright will be assigned exclusively to the JRNM (which is an official journal of Society of Renal Nutrition and Metabolism (SRNM)) and SRNM, including the right to reproduce the article in all forms and media. Authors must sign the copyright transfer agreement.
Role of the funding source
Clearly identify agency of financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If no such agency is involved then this should be stated.
Open Access

JRNM offers you the option of making your article freely available to all via the

Language (usage and editing services) Please write your text in good English ( British).


Manuscripts can be submitted at . Manuscripts that do not comply with these specific guidelines will be returned to the authors for revision prior to being sent out for review or evaluated by the editors.

The submission process of the journal proceeds online only with step-by-step guidance through creating and uploading your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the peer review process, these source files are needed for further processing after acceptance. After submission, the author can log onto the . to view the status of the manuscript. For problems or questions concerning submission, contact Dr Anita Saxena Editor JRNM Editor at .

All accepted manuscripts are subject to editorial revision and shortening. Due to page limitations, the Editors may decide that tables, illustrations, appendices, acknowledgments, and other material should be published online and referenced in the print edition.

Review Process

All submissions are sent to peer reviewers. The identities of both the peer reviewers and the authors are kept confidential. Each manuscript is assigned to an Editor who has expertise in the subject area. After review by the Editor, if the manuscript is judged to be appropriate and competitive for publication in JRNM, it is sent to at least two experts in the appropriate area for anonymous peer review. The reviewers evaluate each article on the basis of content, originality, scientific accuracy, clarity, and contribution to the field of renal nutrition dietetics and science.

The review process generally takes about 45 days. Reviewers provide comments for the editor and for the authors. Minor changes in style and clarity are made at the discretion of the reviewers. All substantial changes will require the approval of the author before typesetting.

After peer review, the corresponding author will be notified whether the manuscript has been accepted, requires revision, or rejected.

The single most important criterion for acceptance is the originality of the work. However, a decision to accept a manuscript is not based solely on the scientific validity of its content. Other factors affecting decisions include the extent and importance of new information in the paper compared with that in other papers being considered, the Journal's need to represent a wide range of topics, and the overall suitability for JRN. Decision letters usually, but not always, convey all factors considered for a particular decision. Occasionally, the comments to the authors may appear to be inconsistent with the editorial decision, which takes into consideration reviewers' comments to the editor, etc.
Revisions and Rejections
Manuscript revisions should be resubmitted within one months of the initial decision; they are carefully reexamined by the editorial team and/or reviewers. However, no guarantee can be made about the final acceptability of the paper. If authors of a rejected manuscript are able to make new advances that go far beyond the original submission, they may consider submitting the manuscript again as a new submission, referring to the original submission in the cover letter
Manuscript Format

Manuscripts must adhere to standard layout and length guidelines. Manuscripts must be submitted in Microsoft Word, double-spaced using 12 pt. font (preferably Times New Roman) and unjustified margins. Pages must be numbered starting with the title page. Include a cover letter to the Editor with the submission stating the main aspects of the research findings of the article. Identify the name of the corresponding author.

Following information is mandatory : names, fields of interest, addresses, telephone and fax numbers, and e-mail addresses of 3 to 4 unbiased and qualified potential expert reviewers from outside the authors' institutions.

Use of the present tense is preferable. Refer to patients by number. Actual names or initials should not be used in the text, tables, or illustrations. All clinical laboratory values should be expressed in U.S. conventional units. If necessary, the International System of Units (SI units) can be provided in parentheses immediately after the U.S. convention units. Conversion tables can be referred to those published in JAMA 1986; 255(17): 2329-2339 or Ann Intern Med 1987;106(1):114-129.

Support and Financial Disclosure Declaration
The title page should acknowledge research support (from funding agencies or industry) and disclose any potential financial conflicts of interest for each author. Any meaningful affiliation or involvement, either direct or indirect, with any organization or entity with a direct financial interest in the subject matter or materials discussed (e.g., employment, consultancies, grants, honoraria) must be disclosed. Specifics of the disclosure will remain confidential. If deemed appropriate by the Editor, a general statement regarding disclosure will be included in the Acknowledgment section of the manuscript. The Acknowledgment section must also reveal all sources of support for the work, both financial and material. If no financial conflict of interest is identified, 'none' should be written next to the author's name.
Abbreviations and Acronyms
Complex terms used frequently in the manuscript may be abbreviated. Abbreviations should be placed in parentheses at first use in the abstract and again at first use in the text. Do not use abbreviations and acronyms in titles.
Figures and Tables

Illustrations include charts, drawings, graphs, and photographs. Charts, drawings and graphs must be computer generated. Each figure should be on a separate page. Number figures consecutively in the order they are to appear in the text (e.g., Figure 1, Figure 2, Figure 3, etc.). Figures should be uploaded as separate files, not embedded in the manuscript file.

For most types of figures, TIFF or EPS files are the preferred format. The resolution for line art must be at least 1200 dpi; photographs and shaded drawings must have a finished resolution of 300 dpi. The following image file formats are not acceptable because they are low resolution: PowerPoint, JPG, GIF,ONG, PCX, PNG, XBM, and Excel. On a separate page, list the legend for each figure, doublespaced, with abbreviations and symbols identified.

Authors must bear all costs associated with printed color figures. The cost of the first color figure is Rs100 ($10) and each additional figure is RS 75.00 ($7). If authors elect not to print figures in color, in most cases, authors will be able to have their color figures produced in black and white for the print version of JRNM, but the figures will appear in color online.


Type each table on a separate page. Do not insert vertical lines in tables. Include a title for each table. Number tables consecutively within the manuscript (Table 1, Table 2, Table 3, etc.). Use standard citation superscript symbols (*, †, ‡, §...). Authors should place footnotes in order. Footnotes should not appear in table titles. Tables should be uploaded as separate files.

If any table or figure has been published previously, a copy of the letter of permission from the copyright holder must accompany the manuscript. The original source of the table or figure should be acknowledged in full reference form in the reference section of the manuscript. The figure legend (or table notes) should conclude with: "Reprinted with permission" followed by the appropriate reference number. Authors are responsible for applying for permission for both print and electronic rights for all borrowed materials, and they are responsible for paying any fees related to the application of these permissions.


References must be numbered according to order of appearance in the text using superscript numbers in the text.

References should be compiled at the end of the manuscript according to the order of citation in the text.

Authors using reference-managing software such as EndNote or Reference Manager should select NLM/PubMed output style.

References should be typed, double-spaced starting on a separate page at the end of the manuscript. When listing references, abbreviate names of journals as listed in PubMed. List all authors and/or editors up to 4; if more than 4, list the first 3 followed by "et al." Journal references should include the issue number in parentheses after the volume number. Accuracy of reference information is the author's responsibility. Please indicate if the source is a complete article, abstract, or editorial; give inclusive page numbers for complete articles. All reference information must be complete when the manuscript is submitted.

Examples of References

Journal Article: Four or Fewer Authors

Ritz E, Rychlik I, Locatelli F, Halimi S: End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999 34 (): 795–808

National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Management of Dyslipidemias in Patients With Kidney Disease. Am J Kidney Dis2003 41 (suppl 3): S1-S91

Accepted manuscripts are sent to the publisher.. Once an article has been copyedited, typeset, and authors have reviewed the proof and submitted corrections, the authorcorrected proof will be uploaded to the JRNM websites ( under "Articles in Press" for pre-print viewing by subscribers..

The corresponding author can expect one set of page proofs in PDF format via e-mail approximately two months after acceptance. The PDF proofs can be annotated using Adobe Reader. Instructions on how to annotate PDF files will accompany the proofs. If the author(s) do not wish to use the PDF annotations function, the corrections can be listed (including replies to the Query Form) and returned to Elsevier via email. Please list corrections quoting line number. If, for any reason, this is not possible, the corrections and any other comments can be sent (including replies to the Query Form) on a printout of the proof and returned by fax, scan or e-mail.

Please only check the typesetting, editing, completeness and correctness of the text, tables and illustrations. Significant changes to the article after it has been accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all corrections are returned to Elsevier in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely the authors' responsibility. Note: With permission from the Editor, Elsevier may proceed with the publication of the article if the proofs are not returned.

Authors are expected to review proofs promptly (within 48 hours of receipt).

Manuscripts are copyedited to make them consistent with the Journal style; if a particular section in the manuscript is not clear or requires additional information, queries will be sent to the author. These "author queries," will appear in the margins of the proofs that are sent to the author. Changes made by the copy editors for style, grammar, and readability should not be altered by the author(s) unless a scientific error has been introduced.
The corresponding author will be provided with a PDF file of the article via e-mail at no cost. Forms for ordering print article reprints will be sent with the proofs to the authors and should be returned with the corrected proofs. An order form with pricing information will be sent to the corresponding author.